SMOX

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, SMOX mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SMOX data layer compared with 21 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SMOX mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated SMOX expression acts as an unfavorable survival marker.

UCEC and LSCC are the cancer types where SMOX mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECOSQuartileAll0.5761.000.00610view →
LSCCDFSMedianIII,IV0.1991.000.0382view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SMOX–UCEC (OS)

Kaplan–Meier survival curve for SMOX mass-spec protein-high vs -low samples in UCEC.

Open the UCEC breakdown →

Exploration